Survival benefit for adjuvant radiation therapy in minor salivary gland cancers

被引:21
作者
Zeidan, Youssef H. [1 ]
Pekelis, Leonid [3 ]
An, Yi [6 ]
Holsinger, Floyd Christopher [4 ]
Kong, Christina S. [5 ]
Chang, Daniel T. [2 ]
Quynh-Thu Le [2 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Radiat Oncol, Miami, FL 33136 USA
[2] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Stat, Stanford, CA 94305 USA
[4] Stanford Univ, Div Head & Neck Surg, Dept Otolaryngol, Sch Med, Stanford, CA 94305 USA
[5] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA
[6] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA
关键词
Minor salivary gland; Radiotherapy; Postoperative; Survival; SEER; Head and neck; ADENOID CYSTIC CARCINOMA; PROGNOSTIC-FACTORS; FUSION; HEAD; MANAGEMENT; MYB;
D O I
10.1016/j.oraloncology.2015.02.096
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: The goal of the current study is to investigate the role of adjuvant radiation therapy (adjuvant RT) in minor salivary gland tumors (mSGT) using an established national database. Methods: The Surveillance, Epidemiology, and End Results (SEER) database was used to identify patients treated with or without adjuvant RT for mSGT from 1988 to 2008. Regression analyses were performed to identify factors associated with improved overall survival (OS). Results: Most tumors were located within the oral cavity (75%) followed by nasal cavity/paranasal sinuses (15%). Multivariate Cox analysis showed that adjuvant RT was associated with better OS compared to surgery alone. Using logistic regression analysis, we provide a novel web based tool for predicting survival impact of adjuvant RT in patients with mSGT. Conclusions: Adjuvant RT is associated with improved survival in patients with mSGT and adverse clinicopathologic factors such as advanced T/N category, adenoid cystic histology, high grade, and nasopharynx location. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:438 / 445
页数:8
相关论文
共 29 条
  • [1] Biology and Management of Salivary Gland Cancers
    Adelstein, David J.
    Koyfman, Shlomo A.
    El-Naggar, Adel K.
    Hanna, Ehab Y.
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2012, 22 (03) : 245 - 253
  • [2] Determinants of survival in parotid gland carcinoma: a population-based study
    Bhattacharyya, N
    Fried, MP
    [J]. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2005, 26 (01) : 39 - 44
  • [3] Radiation Therapy for Minor Salivary Gland Carcinoma
    Cianchetti, Marco
    Sandow, Pamela S.
    Scarborough, Lauren D.
    Morris, Christopher G.
    Kirwan, Jessica
    Werning, John W.
    Mendenhall, William M.
    [J]. LARYNGOSCOPE, 2009, 119 (07) : 1334 - 1338
  • [4] Edge S B., 2009, AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual
  • [5] Adenoid cystic carcinoma of the head and neck
    Ellington, Christopher L.
    Goodman, Michael
    Kono, Scott A.
    Grist, William
    Wadsworth, Trad
    Chen, Amy Y.
    Owonikoko, Taofeek
    Ramalingam, Suresh
    Shin, Dong M.
    Khuri, Fadlo R.
    Beitler, Jonathan J.
    Saba, Nabil F.
    [J]. CANCER, 2012, 118 (18) : 4444 - 4451
  • [6] The relationships among fluoride, cariogenic oral flora, and salivary flow rate during radiation therapy
    Epstein, JB
    Chin, EA
    Jacobson, JJ
    Rishiraj, B
    Le, N
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1998, 86 (03): : 286 - 292
  • [7] MULTIVARIATE ADAPTIVE REGRESSION SPLINES
    FRIEDMAN, JH
    [J]. ANNALS OF STATISTICS, 1991, 19 (01) : 1 - 67
  • [8] GARDEN AS, 1994, CANCER, V73, P2563, DOI 10.1002/1097-0142(19940515)73:10<2563::AID-CNCR2820731018>3.0.CO
  • [9] 2-X
  • [10] Goel MK, 2011, INT J AYURVEDA RES, V1, P274